Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
IFN-lambda therapy: Current status and future perspectives
Ahmed Lasfar
, Andrew Zloza
, Karine A. Cohen-Solal
Research output
:
Contribution to journal
›
Review article
›
peer-review
30
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'IFN-lambda therapy: Current status and future perspectives'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Lambda
100%
Interferon lambda (IFN-λ)
100%
Viral Infection
25%
Autoimmune Disease
12%
Innate Immunity
12%
Cell Response
12%
Infectious Diseases
12%
Clinical Trials
12%
Disease Targets
12%
Chronic Hepatitis C Virus Infection
12%
Adverse Events
12%
Response Pattern
12%
IFN Therapy
12%
Role in Cancer
12%
Type III IFN
12%
Potential Clinical Applications
12%
Pharmacology, Toxicology and Pharmaceutical Science
Interferon
100%
Malignant Neoplasm
28%
Virus Infection
28%
Clinical Trial
14%
Adverse Event
14%
Autoimmune Disease
14%
Chronic Hepatitis C
14%
Diseases
14%
Immunology and Microbiology
interferon
100%
Viral Disease
28%
Innate Immune System
14%
Autoimmune Disease
14%
Hepatitis C
14%